ArticleBlood2021

CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma.

John H Baird et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.